Prostate cancer Cancer Prostate cancer
Conditions
Interventions
Patients are randomly assigned in a 1:1:1 ratio to one of three groups using a computer-generated list of random numbers. Patients are allocated by an independent third party to ensure that the random
Sponsors
Science Technology Department of Zhejiang Province
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Male 2. Under 85 years of age 3. Verified prostate-specific antigen (PSA) > 4 ng/ml and/or abnormal DRE 4. Provision of signed informed consent
Exclusion criteria
Exclusion criteria: 1. No signed informed consent 2. Patients who have been included in published cohorts
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prostate cancer detection rate is assessed through medical record review 1 week post-test. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The positive rate for biopsy cores is assessed through medical record review 1 week post-test 2. The number of biopsy cores needed to detect one prostate cancer is acquired through medical record review 1 week post-test 3. In mpMRI group, the prostate cancer detection rate for each PI-RADS category is acquired through medical record review 1 week post-test | — |
Countries
China
Outcome results
None listed